1. Home
  2. PD vs NBTX Comparison

PD vs NBTX Comparison

Compare PD & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PagerDuty Inc.

PD

PagerDuty Inc.

N/A

Current Price

$7.58

Market Cap

987.5M

Sector

Technology

ML Signal

N/A

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

N/A

Current Price

$38.32

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PD
NBTX
Founded
2009
2003
Country
United States
France
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
987.5M
1.0B
IPO Year
2019
2018

Fundamental Metrics

Financial Performance
Metric
PD
NBTX
Price
$7.58
$38.32
Analyst Decision
Buy
Strong Buy
Analyst Count
9
1
Target Price
$17.00
$26.00
AVG Volume (30 Days)
3.5M
38.2K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
33.71
N/A
EPS
1.73
N/A
Revenue
$467,499,000.00
N/A
Revenue This Year
$8.16
N/A
Revenue Next Year
$3.75
$11.73
P/E Ratio
$4.60
N/A
Revenue Growth
8.54
N/A
52 Week Low
$6.18
$2.95
52 Week High
$19.70
$37.11

Technical Indicators

Market Signals
Indicator
PD
NBTX
Relative Strength Index (RSI) 42.83 71.17
Support Level $6.18 $20.11
Resistance Level $16.48 N/A
Average True Range (ATR) 0.37 2.41
MACD 0.29 1.09
Stochastic Oscillator 74.40 80.06

Price Performance

Historical Comparison
PD
NBTX

About PD PagerDuty Inc.

PagerDuty Inc is a digital operations management platform that manages urgent and mission-critical work for a modern, digital business. Its PagerDuty Operations Cloud combines artificial intelligence (AI) operations (AIOps), automation, customer service operations, and incident management with a generative AI assistant to create a flexible, resilient, and scalable platform to protect revenue and improve customer experience, improve operational efficiency, and mitigate the risk of operational failures. The company generates revenue predominantly from cloud-hosted software subscription fees and term-license software subscription fees. Geographically, the firm derives a majority of its revenue from the United States and the rest from International markets.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Share on Social Networks: